depixus
(5)
The Secrets of Protein-Protein Interactions: MAGNA™ Technology Revolutionizes Drug Discovery
Protein-protein interactions (PPIs) are the intricate dance that underlies nearly every cellular process. These interactions dictate how proteins function, and malfunctions in these dances are linked to a vast array of diseases, from cancer to neurod...
Petrick Zag · 04 April · 1
Explore Drugs Targeting RNA Riboswitches with Magna - Depixus
We’ve been working with Dr Jay Schneekloth, a leading expert in RNA-targeted drug discovery, to use our MAGNA™ technology to probe the interactions between the PreQ1 bacterial riboswitch and its natural ligand or a synthetic small molecul...
Petrick Zag · 21 March · 1
Depixus Wins SLAS2024 Ignite Award for MAGNA Technology - Depixus
Paris, France – Interactomics pioneer Depixus has won the prestigious Society for Laboratory Automation and Screening (SLAS) Ignite Award at the society’s annual International Conference and Exhibition in Boston, MA, for their novel MAGNA...
Petrick Zag · 07 March · 1
Depixus: Decoding Disease Mechanisms with Magnetic Force Spectroscopy
In the ever-evolving field of healthcare, new discoveries are constantly being made, paving the way for advancements in disease diagnosis and treatment. Depixus, a pioneering company, is at the forefront of this progress, introducing a groundbreaking...
Petrick Zag · 28 February · 1
How MAGNA™ Technology is Revolutionizing the Study of Biomolecular Interactions
In the world of science, understanding how molecules interact with each other is crucial for developing new drugs, diagnostics, and other life-saving technologies. However, traditional methods for studying these interactions are often time-consuming,...
Petrick Zag · 07 February · 1